| Trial registration number
|
NCT05197569 |
Full text link
Last imported at : Jan. 20, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT05197569
|
First author
Last imported at : Jan. 20, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
Zeliha CENGİZ, Dr. Lecturer Member of
|
Contact
Last imported at : Jan. 20, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
zeliha.cengiz@inonu.edu.tr
|
Registration date
Last imported at : Jan. 20, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
2022-01-19
|
Recruitment status
Last imported at : April 1, 2023, 8 a.m.
Source : ClinicalTrials.gov
|
Recruiting
|
Study design
Last imported at : Jan. 20, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : Jan. 20, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : Jan. 20, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : Jan. 20, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
Blind label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
single-center
|
Study aim
Last imported at : Jan. 20, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
Treatment
|
Inclusion criteria
Last imported at : Jan. 20, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
pcr test positive
being in the covid-19 service
involvement in the lung as a result of computed tomography between 50-80% to be
the day of admission to the covid 19 service (1. day) sickareceipt of
|
Exclusion criteria
Last imported at : Jan. 20, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
having a pregnancy status
be under the age of 18
unwillingness to participate in the study
patients who will be transferred to the intensive care unit will be excluded from the study.
|
Number of arms
Last imported at : Jan. 20, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
2
|
Funding
Last imported at : Jan. 20, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
Inonu University
|
Inclusion age min
Last imported at : Jan. 20, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
18
|
Inclusion age max
Last imported at : Jan. 20, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
100
|
Countries
Last imported at : Jan. 20, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
Turkey
|
Type of patients
Last imported at : Jan. 20, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
Moderate/severe disease at enrollment
|
Severity scale
Last imported at : Jan. 20, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
4: Moderate/severe disease at enrollment
|
Total sample size
Last imported at : Jan. 20, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
140
|
primary outcome
Last imported at : Jan. 20, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
Covid-19 Symptom Form;Demographic Characteristics Form;Hemodynamic parameters form;Visual Comparison Scale;Vital signs follow-up form
|
Notes
Last imported at : Jan. 20, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : Jan. 20, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
Not reported
|
Arms
Last imported at : Jan. 20, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "", "treatment_id": 2127, "treatment_name": "Thyme oil", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]
|